Glucose -6- phosphate dehydrogenase (g6pd) activity and deficiency in a population of Nigerian males resident in jos by Egesie, O.J et al.
9 
 
Nigerian Journal of Physiological Sciences 23 (1-2): 9-11 ©Physiological Society of Nigeria, 2008 
Available online/abstracted at http://www.bioline.org.br/np; www.ajol.info/journals.njps; www.cas.org 
GLUCOSE -6- PHOSPHATE DEHYDROGENASE (G6PD) ACTIVITY AND 
DEFICIENCY IN A POPULATION OF NIGERIAN MALES RESIDENT IN JOS 
 
O. J. EGESIE, D. E. JOSEPH, I. ISIGUZORO
1
, U. G. EGESIE
2 
Departments of Haematology and Blood Transfusion, Jos University Teaching Hospital, Jos. 
1Chemical Pathology, Jos University Teaching Hospital, Jos, Nigeria, 
 2 Human Physiology, Faculty of Medical Sciences, University of Jos, Nigeria. 
Email: juliegesie@yahoo.com, egesiej@unijos.edu.ng  
 
Summary: The activity of red blood cell Glucose 6-phosphate dehydrogenase (G6PD) in one hundred and 
twenty six healthy male individuals who are Nigerians residing in Jos was evaluated. The enzyme activity was 
determined quantitatively by spectrophotometer assay method. The activity of red cell G6PD enzyme was 
subnormal in 20% of the population studied. This agrees with previous report of the prevalence of G6PD 
deficiency in Nigerian males from the Western region of the country which is between 20 and 26%. The 
proportion of Nigerian males with subnormal G6PD activity is relatively constant irrespective of their 
geographical location.  
 





Glucose-6-phosphate dehydrogenase (G6PD) 
is a cytoplasmic enzyme that is distributed widely 
in all cells. It catalyses the first step in the hexose 
monophosphate pathway, producing nicotinamide 
adenosine dinucleotide phosphate in the reduced 
form (NADPH) (Luzzatto, 2001). This co-enzyme 
is required as hydrogen donor for numerous 
reductive processes of various biochemical 
pathways as well as for the stability of catalase and 
the preservation and regeneration of the reduced 
form of glutathione (Luzzatto, 1995). Catalase and 
glutathione are both essential for the detoxification 
of hydrogen peroxide and free radicals generated 
during the normal cellular metabolic processes 
(Luzzatto, 2001). The defence of cells against 
hydrogen peroxide, free radicals and other forms of 
oxidative stress, therefore, ultimately and heavily 
depend on G6PD for the generation of NADPH. 
The red cells are exquisitely sensitive to oxidative 
damage in the absence or reduced activity of G6PD 
as they lack other NADPH-producing enzymes 
(Luzzatto 1995). 
G6PD deficiency resulting in decreased 
activity of the enzyme is the most common 
enzymopathy known worldwide with about 400 
million people affected (Mason 1996). In 
Nigerians, the prevalence of G6PD deficiency 
ranges from 4 – 26% with the male population 
having about 20 – 26% (Luzzatto 2001, Ademowo 
2002). This prevalence rate varies from one 
community to another. The paucity of reported 
information on the pattern of distribution of G6PD 
activity and the proportion of G6PD deficient male 
individuals in our locality have prompted the need 
to embark on this study. We therefore report G6PD 
activity and deficiency in a population of Nigerian 
males resident in Jos. 
 
Materials and methods 
 Subjects 
One hundred and twenty six (126) consecutive 
healthy male blood donors at the blood bank unit of 
the Jos University Teaching Hospital who were 
resident in Jos and gave their consent were studied. 
They were aged between 20 and 49 years and all 
Nigerians irrespective of tribe. 
Sample collection 
Two millilitres of blood were collected using 
aseptic procedure from the most prominent 
peripheral vein in the antecubital fossa of each 
subject. The blood was emptied into Ethylene 
diamine tetra acetic acid (EDTA) bottle and gently 
mixed. The blood sample was then stored at 4
0
C in 
a refrigerator till required for use. All blood 




Determination of G6PD activity 
G6PD activity was determined by quantitative 
assay of the enzyme activity in erythrocytes based 
on the Sigma Diagnostic procedure for quantitative 
determination of G6PD using Sigma Diagnostic kit 
(Sigma-Aldrich co. St Louise, USA). Decreased 
activity or G6PD deficiency was taken as any level 
of enzyme activity less than 4.6 I.U/g haemoglobin 
(reference range 4.6 – 13.5 IU/g haemoglobin) 
(Sigma Diagnostic Procedure 2001). 
Calculation of G6PD enzyme activity in 
erythrocytes 
 ∆A per min = final A – initial A ÷ 5,  G6PD 
(IU/gHb) = ∆A/min X 4839 X tcf ÷ Hb (g/dl) 
Where tcf is temperature correction factor,  A = 
absorbance at 340nm wavelength,   ∆ = change in 
absorbance 
 
Haemoglobin concentration was determined 
using an automated coulter counter.  Statistical 
analyses were determined using statistical software 
epi-info computer package. Results were expressed 
as mean ±SD and presented in tables. 
 
Results 
Table 1 shows the age distribution of the 
subjects studied. Majority (80%) of the subjects 
had normal enzyme activity ranging from 5.25 to 
14.27 IU/gHb. However, a small proportion (20%) 
had subnormal enzyme activity with G6PD activity 
ranging between 2.25 to 4.43 IU/gHb. (Table 2). 
The age distribution of the individuals that have 
reduced or deficient G6PD activity is summarized 
in Table 3. 
 
Table 1: Age distribution of subjects studied 
Age (years) No of subjects 
20 – 24 42 (33.3%) 
225 – 29  34 (27.0%) 
30 – 34 24 (19.0%) 
35 – 39 8 (6.3%) 
40 – 44 12 (9.5%) 
 
Table 2: Subjects and their G6PD activity 
n G6PD activity 
level (IU/gHb) 
G6PD status % 
26 3.34± 1.09 Deficient 20 
100 9.76 ±4.51 Normal 80 
 
 
Table 3: Age distribution of G6PD deficient 
subjects 
Age(years) n Percentage 
20-24 4 15.4 
25-29 6 23.0 
30-34 4 15.4 
35-39 6 23.0 
40-44 2 7.7 
45-49 4 15.4 
Total  26 100 
 
Discussion 
The prevalence of glucose 6-phosphate 
dehydrogenase (G6PD) deficiency in Nigerians has 
been put at 4- 26% and 20-26% among male 
Nigerians (Luzzatto 1975). Much of the work 
culminating in the report of G6PD activity and 
deficiency was done in the mid 1970s and 1980s 
from the South Western region of Nigeria; although 
isolated report of G6PD deficiency in specific 
clinical conditions were made from the North 
Eastern region of Nigeria (Tugwell, 1973), very 
limited report of G6PD activity and deficiency in 
healthy population in the North Central region of 
Nigeria is available as far as the authors are aware. 
In this study, 20% of the subjects studied 
had G6PD enzyme activity below the normal 
reference range and so are G6PD deficient. This 
proportion of G6PD deficient individuals fall 
within the range reported for Nigerians from other 
parts of the country and collaborates with the report 
from a community in South Western part of Nigeria 
in male individuals studied (Ademowo and Falusi 
2002). It may then be that the prevalence of G6PD 
deficiency among Nigerian males irrespective of 
their geographical location is relatively constant. 
This study confirms the prevalence rate of 20% of 
Nigerian males deficient in G6PD. 
G6PD deficiency is beneficial as it is 
known that red cells that are deficient in G6PD are 
resistant to Plasmodium falciparum invasion since 
the parasite require the enzyme for its normal 
survival in the host cell (Ruwende 1995, Tishkoff 
2001). This deficiency offers a selective protection 
against P.falciparum malaria (Roth et al, 1983). It 
has, however, been reported that some 
P.falciparum parasite strains have been able to 
synthesize their own G6PD enzyme thereby 
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evading the immunity offered by G6PD deficiency 
in such individuals (Usanga and Luzzatto 1985).  
G6PD deficiency is also known to be associated 
with decreased phagocytic and bactericidal activity 
of phagocytes (Owusu 1978, Luzzatto 1975). This 
may predispose G6PD deficient individuals to 
increased bacterial infections. 
G6PD deficient individuals are asymptomatic 
until they are exposed to oxidative stress. Oxidative 
stress which results in acute haemolytic anaemia 
include ingestion of drugs among other factors such 
as infection, chemicals and ingestion of some food 
stuffs (Luzzatto 1975). It may then be necessary for 
males in our locality to know their G6PD status so 
that those found to be deficient can avoid the 
trigger factors for acute haemolytic attack such as 
indiscriminate ingestion of drugs. 
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